| Code | Description | Claims | Beneficiaries | Total Paid |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
26,463 |
6,538 |
$510K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
20,126 |
5,233 |
$281K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
11,813 |
4,670 |
$175K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,102 |
998 |
$71K |
| 97162 |
|
2,258 |
1,942 |
$66K |
| 29848 |
|
103 |
98 |
$52K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
3,219 |
1,148 |
$50K |
| 97161 |
|
1,246 |
1,095 |
$48K |
| 64721 |
|
174 |
161 |
$35K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
298 |
269 |
$20K |
| 73221 |
|
279 |
259 |
$19K |
| 26055 |
|
119 |
75 |
$18K |
| 81025 |
|
869 |
806 |
$14K |
| 82962 |
|
573 |
411 |
$10K |
| 80047 |
|
471 |
387 |
$9K |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
990 |
311 |
$8K |
| 97164 |
|
295 |
255 |
$7K |
| 97035 |
|
720 |
282 |
$7K |
| 97116 |
|
309 |
137 |
$3K |
| 76942 |
|
375 |
356 |
$3K |
| 99205 |
Prolong outpt/office vis |
80 |
56 |
$2K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
1,177 |
1,038 |
$1K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
13 |
13 |
$1K |
| 85027 |
|
257 |
215 |
$898.34 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
171 |
131 |
$306.00 |
| 36415 |
Collection of venous blood by venipuncture |
1,350 |
991 |
$138.54 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,686 |
1,277 |
$131.71 |
| 82040 |
|
44 |
39 |
$95.83 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
697 |
607 |
$66.72 |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
1,275 |
1,147 |
$65.88 |
| J0697 |
Injection, sterile cefuroxime sodium, per 750 mg |
306 |
253 |
$37.62 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,252 |
1,019 |
$19.06 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
278 |
211 |
$17.16 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
17 |
15 |
$14.68 |
| J2704 |
Injection, propofol, 10 mg |
1,228 |
1,045 |
$10.16 |
| 36416 |
|
494 |
346 |
$7.16 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
903 |
721 |
$6.23 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,016 |
749 |
$4.44 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
46 |
38 |
$0.30 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
346 |
270 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
46 |
25 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
51 |
40 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
36 |
26 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
49 |
38 |
$0.00 |